Contact Us
Contact Us

Global Team

Image Analysis Group’s success is built on the unrivaled expertise and collaboration of our global team. Led by visionary scientists, medical imaging leaders, and clinical trial strategists headquartered in London, UK, our organization spans 4 continents, with offices in the USA, EU, UK, India and additional operations throughout China and Australia.

Contact Us

Senior Leadership Team

Dr. Olga Kubassova

CEO and President
Extensive expertise in identifying innovative approaches to clinical research, disruptive technology platforms and novel therapeutics.
Michael Clark, PMP

Chief Operating Officer
Holding 30+ years of experience in managing clinical trials and optimizing imaging solutions.

Jon Himoff

Chief Product Officer
Leading the development of DYNAMIKA™,
IAG’s cloud platform for data management, AI and tech innovation strategy.
Dr. Anitha Singareddy

Head of Medical Affairs
MD leading scientific and medical services, building global network for IAG.

Jonathan Shaul

Chief Finance Officer
Driving financial governance and overseeing M&A strategy.
Derek Hunter, Head of Quality at Image Analysis Group (IAG)
Derek Hunter

Head of Quality
Bringing 25+ years of industry experience, currently leading the development and implementation of IAG’s global quality strategy.

Expert Network

Mikael Boesen, MD, PhD

Senior Therapeutic Area Lead: Rheumatic and Autoimmune Clinical Research

Prof. Mikael Boesen, MD, PhD is a prominent consultant musculoskeletal radiologist and expert in advanced imaging techniques, renowned for his contributions to drug development in autoimmune and musculoskeletal diseases.

His expertise is in quantification of soft tissue and bone inflammation in the joints and muscles using ultrasound, MRI, dynamic contrast enhanced MRI (DCE-MRI), CT, Xray and DXA.
Sotirios Bisdas, MD, PhD

Senior Therapeutic Area Lead: Neuroimaging and Neuro-Radiology Clinical Research

Prof. Sotirios Bisdas, MD, PhD is distinguished consultant neuroradiologist, renowned for his expertise in advanced imaging techniques, he plays a pivotal role in drug development for neuro-oncology, contributing to innovative therapeutic strategies for brain diseases.

His expertise fields include advanced CT, intraoperative MRI, advanced and functional MRI and molecular MR-PET imaging in brain diseases.
Julia O’Lynn

Radiologic Cross-Sectional Imaging Expert

Julia O’Lynn is a radiologic cross-sectional imaging expert and Director of Imaging at IAG, Image Analysis Group, where she brings extensive hands-on MRI and CT experience from her many years as a lead MRI technologist into the design and delivery of imaging strategies for clinical trials.

Her expertise fields include advanced MRI and CT acquisition and protocol optimization, centralized imaging review workflows, and operational oversight of imaging components in oncology and immunology studies for biotech and pharma sponsors.
Benjamin M. Ellingson, Ph.D.

Brain Tumor Imaging and Neuro-Oncology

Professor Benjamin M. Ellingson, PhD, MS is a leading brain tumor imaging expert and Professor of Radiology at UCLA, where he serves as Director of MRI Research and directs the UCLA Brain Tumor Imaging Laboratory within the UCLA Brain Tumor Program.

His expertise fields include advanced functional and structural MRI, diffusion and perfusion MRI, quantitative imaging biomarkers, and MRI–PET methods for characterizing brain tumor biology and evaluating response to novel therapies in clinical trials.
Professor Rajiv Jalan

Obesity and Liver Diseases Expert

Professor Rajiv Jalan is a leading hepatologist, director at the European Foundation for the Study of Chronic Liver Failure, founder of EASL CLIF Consortium and PI in studies of MASH, NASH, Obesity, who directly contributed to discovery of novel drugs to treat liver diseases.

Expertise in MRI, Fibroscan, biomarkers to design effective studies that support development of novel drug candidates.

480 original papers, editorials and reviews.
Dr. John Howard Sampson, M.D., Ph.D, M.B.A, M.H.S.c

Brain Tumor Imaging Expert

John H. Sampson is an American neurosurgeon and internationally recognized expert in brain tumors, particularly in immunotherapy for glioblastoma and other complex central nervous system cancers. He serves as Dean of the University of Colorado School of Medicine and Vice Chancellor for Health Affairs at the CU Anschutz Medical Campus, following a long career at Duke University where he was the inaugural chair of the Department of Neurosurgery and held the Robert H. and Gloria Wilkins Distinguished Professorship.
Prof. Hani Gabra, MD

Cancer Research and Drug Development

Professor Hani Gabra, MD, PhD is an internationally recognized medical oncologist and cancer researcher, Emeritus Professor of Medical Oncology at Imperial College London and Consultant Medical Oncologist with a long-standing focus on ovarian and other gynaecological cancers.

He has extensive leadership experience in translational cancer research and oncology drug development, including senior roles in biotech and pharma, where he has led biomarker-driven clinical trials and development programs for novel targeted and immuno-oncology therapies.
Natalie Faye, MD, PhD

Women’s Health Radiology Expert

Natalie Faye, MD, PhD  is a board-certified radiologist with over 20 years of experience in imaging for clinical trials with the biopharmaceutical industry.

In depth experience in using imaging and functional imaging in development of novel agents in women health, endometriosis, fertility, breast cancer.

John Carrino, MD, MPH

Musculoskeletal Imaging Expert

John Carrino, MD, MPH is internationally renowned radiologist specializing in diagnostic imaging and image-guided interventions, with over 200 peer-reviewed publications. He actively participates in musculoskeletal imaging research and leadership within relevant medical societies. He has served on the Advisory Committee of the FDA Radiology Devices Panel, looking at computer aided diagnosis.

Expertise in Neuromuscular, Rheumatology, Bone Health, Spine with MRI, CT, US, Radiography, and Image Guided Intervention (fluoroscopy, CT, US) of spine and extremities.
Prof. David Rubin

Gastroenterology

Prof. David Rubin is a prominent gastroenterologist recognized for his expertise in inflammatory bowel disease (IBD) and his role as a principal investigator in clinical research. As a leading investigator,

Dr. Rubin has participated in numerous clinical trials, helping to evaluate new treatments and refine existing ones. His research not only focuses on therapeutic interventions but also explores the role of imaging and biomarkers in monitoring disease progression and treatment efficacy.

Francesca Mulero, MD, PhD

Nuclear Medicine and Radiopharma

Francesca Mulero, MD, PhD, is a distinguished expert in nuclear medicine, Since 1994, she worked with with Scintigraphy Specialists and PET-CT Specialists. Dr. Mulero is a certified Supervisor of Radioactive Installations by CSN.

She received a Dupont Fellowship for her study on Tc-99m Sestamibi Scintimammography and holds degrees in PET Scanning for breast cancer and Alzheimer’s evaluation. Since 2007, she leads the Molecular Imaging Core Unit at CNIO.
Dr. Michael Brun

Pulmonary Imaging Expert

Dr. Michael Brun is a distinguished specialist in pulmonary medicine, recognized for his significant contributions as a principal investigator in lung-related clinical trials. With a focus on respiratory diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer, Dr. Brun is committed to advancing understanding and treatment strategies for these conditions and leverages his expertise to design and conduct studies that assess safety and efficacy.
Dr. Memon

Ophthalmology

Dr. Memon is an Ophthalmologist with extensive clinical experience. He currently serves as Medical Retina and Clinical Trials Fellow at Moorfields Eye Hospital in London, UK, where he is involved in the management of Age-related Macular degeneration, Diabetic Retinopathy, Retinal Vascular diseases, Uveitis and Retinal dystrophies-related clinical trials.

Over the course of his career, he has developed surgical, laser and clinics skills for a multitude of eye and vision care conditions.
Mette Mogensen, MD, PhD, Assoc. Prof

Dermatology Imaging

Mette Mogensen, MD, PhD, Assoc. Prof., Chief Consultant in Dermatology, Dept. of Dermato-Venereology Bispebjerg Hospital, University Hospitals of Copenhagen. She brings 20 years of medical and clinical dermatological experience and is skilled in conducting clinical trials in dermatology – taking new devices from bench to bedside and working with technologies such as nailfold video capillaroscopy, high-frequency ultrasound, in vivo reflectance and fluorescence confocal microscopy, photoacoustic imaging and OCT.

Her interests are diagnostic imaging of skin cancer and inflammatory skin diseases.
Professor Francesco Del Galdo

Scleroderma

Professor Francesco Del Galdo is a leading expert in scleroderma research and treatment. In 2009, Professor Del Galdo moved to Leeds to establish the NIHR Scleroderma Research Program within the Biomedical Research Centre and the Raynaud’s and Scleroderma clinical excellence centre for Yorkshire and the Humber.

His research program has pioneered the application of Optical Coherence Tomography as a virtual skin biopsy, DAVIX score (MRI based) and the use of serum biomarkers for overall fibrosis as outcome measures of activity and early diagnosis in scleroderma.
Professor Viktor Koelzer

Pathology

Professor Viktor Koelzer is a leading expert in digital pathology, gastrointestinal pathology, and oncology. He holds the first professorship for digital pathology in Switzerland at the University of Zurich, with a key focus on digitalizing clinical pathology diagnostics and research at the University Hospital Zurich.

Professor Koelzer’s work aims to advance the field of pathology through digitalization and computational approaches. His research has the potential to improve diagnostic accuracy and efficiency in clinical pathology.
Prof. Henning Bliddal, MD, DMSc

Osteoarthritis and Obesity Research

Prof. Henning Bliddal, MD, DMSc, is a renowned expert in musculoskeletal research, particularly in the field of osteoarthritis. He has made significant contributions to understanding and treating degenerative and inflammatory joint diseases, and obesity.

With over 150 peer-reviewed articles and leading numerous research projects focusing on advancing treatments for major disease groups such as osteoarthritis, rheumatoid arthritis, and soft tissue pain conditions.

Professor Emilio Vanoli

Cardiovascular

Professor Emilio Vanoli is a distinguished figure in the field of cardiology and cardiovascular research. With a career spanning several decades, Prof. Vanoli has made significant contributions to the understanding and treatment of cardiovascular diseases and is widely recognized for his distinguished clinical and research contributions.

He is an active advisor and Investigators in clinical trials that involve development of novel therapeutics for oncology, cardio-vascular and metabolic diseases.

Dr Lee Simon

Regulatory Consulting Partner

Dr Lee Simon is a prominent figure in rheumatology and drug development with extensive experience in both clinical practice and regulatory affairs. He served as the FDA’s Division Director of Analgesic, Anti-inflammatory and Ophthalmologic Drug Products from 2001 to 2003.

His expertise spans clinical rheumatology, drug development, and regulatory affairs, making him a valuable advisor in the field of rheumatology and pain management.
Dr Scott Bruder

Regulatory Consulting Partner

Dr Scott Bruder work has significantly advanced the understanding and clinical application of regenerative medicine in orthopaedics, particularly in the areas of bone and cartilage repair.

He has served as CMO of Stryker, VP of Biologics in DePuy and on FDA advisory committees and industry boards related to cellular therapies and regenerative medicine, which have implications for orthopedic treatments.
Dr. Sven Kili

Cell and Gene Therapy Expert

Dr. Sven Kili is a prominent figure in the cell and gene therapy (CGT) industry with extensive experience in clinical development, regulatory affairs, and strategic leadership. He led development of ex-vivo gene therapies, including Strimvelis®, the first approved ex-vivo gene therapy for ADA-SCID.

He chaired of several boards, including UK BIA CGTAC and ARM Gene Therapy committee.
Dr. Jan Lundberg MD, PhD

Scientific Advisory Board for Novel Drug Discovery and Development

Dr. Jan Lundberg, MD, PhD joined Image Analysis Group (IAG) in 2018 as Chair of the Scientific Advisory Board and serves as a Non-Executive Director. With more than 20 years of global pharmaceutical R&D leadership at Eli Lilly, AstraZeneca, and Karolinska Institutet, he brings deep expertise in drug discovery, development, and strategic planning. At IAG, Dr. Lundberg guides the company’s scientific vision, drives strategic partnerships, and advises on the use of advanced imaging and AI to accelerate clinical trials and de-risk drug development across therapeutic areas, including Alzheimer’s imaging with amyloid and tau PET.
Jeff Bockman, PhD

Regulatory Oncology Consulting Partner

Jeff Bockman, PhD, is a prominent figure in the pharmaceutical and biotechnology industries, specializing in oncology and virology.

Dr. Bockman has made significant contributions to the field, directed numerous licensing opportunity and valuation assessments and worked closely with Nobel Prize recipients Dr. Sidney Altman (ribozymes) and Dr. Stanley Prusiner (prions).
Prof. Philip J. Mease, MD

Specialist in Psoriatic Arthritis, Spondyloarthritis, Rheumatoid Arthritis, Fibromyalgia, Lupus

Prof. Philip J. Mease, MD is a leading rheumatologist, serving as Clinical Professor at the University of Washington, Director of Rheumatology Research at Swedish Medical Center, and practicing at Seattle Rheumatology Associates. Educated at Stanford University and the University of Washington, he has authored over 550 publications and helped develop key outcome measures in psoriatic arthritis, spondyloarthritis, rheumatoid arthritis, osteoarthritis, fibromyalgia, and lupus. A founding organizer and past President of GRAPPA, and member of ASAS and SPARTAN, he is widely recognized as a top global expert in psoriatic arthritis.
Michael Clark PMP

Chief Operating Officer
Bone Health Expert

Michael Clark is the Chief Operating Officer at Image Analysis Group (IAG), bringing extensive experience in clinical project management and global imaging trials. His expertise in clinical operations and medical imaging is highly relevant to bone health, including the use of DXA (Dual-Energy X-ray Absorptiometry) to assess bone mineral density and body composition. At IAG, he works with specialists in musculoskeletal imaging and novel therapeutics for rheumatic and autoimmune conditions, helping to build teams and scale capabilities that support bone health research, osteoporosis studies, and drug development in bone-related disorders.
Dr. Ty K. Subhawong

Musculoskeletal Imaging, with a Particular Focus on Bone and Soft Tissue Sarcoma

Dr. Ty K. Subhawong is a distinguished musculoskeletal radiologist with a focus on bone and soft tissue sarcoma, serving as Division Director of Musculoskeletal Radiology and Vice Chairman of Research at the University of Miami Miller School of Medicine. Educated at Vanderbilt University, he holds a BS in Chemistry, Summa Cum Laude, and an MD, and is Professor of Clinical Radiology, Director of the Musculoskeletal Radiology Fellowship, and an attending radiologist at Jackson Memorial Medical Center and University of Miami Hospital & Clinics. With over 75 peer-reviewed publications, his research centers on imaging biomarkers and innovative tumor assessment, and as a member of IAG’s Scientific Advisory Board he helps shape musculoskeletal imaging strategy and imaging endpoints in oncology.
Prof. Henning Bliddal, MD, DMSc

Osteoarthritis and GLP-1 Obesity Drug Development Expert

Prof. Henning Bliddal, MD, DMSc is a leading expert in osteoarthritis and musculoskeletal disease, serving as Director and Research Professor at the Parker Institute and Clinical Professor at the University of Copenhagen. His work has focused on knee osteoarthritis, soft tissue pain, and weight-loss interventions for musculoskeletal disease, including randomized trials of GLP-1–based obesity treatments such as liraglutide to improve outcomes in osteoarthritis. As Scientific Advisor and Clinical Osteoarthritis Expert at Image Analysis Group (IAG), he helps shape osteoarthritis strategy and imaging approaches supporting GLP-1 obesity drug development and rheumatology clinical trials.
Prof. Mikkel Østergaard, MD, PhD, DMSc

Scientific Advisor
Rheumatology & Imaging Expert

Prof. Mikkel Østergaard, MD, PhD, DMSc is a leading rheumatologist with a special focus on advanced imaging in inflammatory arthritis. His primary interests are MRI and ultrasound of joints affected by rheumatoid arthritis and related inflammatory arthritides, where he has helped define and validate imaging biomarkers of inflammation and structural damage. Prof. Østergaard has co-authored more than 125 scientific articles in this field and has played a key role in numerous national and international clinical and imaging studies, supporting smarter trial design and more sensitive assessment of treatment response.
Dr. Guillermo Valenzuela , MD

Clinical Rheumatology Expert

Dr. Daniel Valenzuela is a leading rheumatologist based in Plantation, Florida, where he runs one of the largest state-of-the-art rheumatology practices. Trained at the University of Buenos Aires, New York Medical College, and Cornell University Medical College, he has extensive experience managing complex arthritic and rheumatic diseases, with particular expertise in rheumatoid arthritis, osteoporosis, carpal tunnel syndrome, lupus (SLE), gout, Sjögren’s syndrome, and ankylosing spondylitis. Dr. Daniel Valenzuela is actively involved in clinical studies, contributing to the development of new treatments for patients with challenging rheumatologic conditions.
Dr. Robert Stein, MD, PhD Scientific Advisor

Scientific Advisor
Preclinical & Translational Drug Development Expert

Dr. Philip Stein, MD, PhD is IAG’s Scientific Expert in preclinical development and translational medicine, bringing more than 30 years of biopharmaceutical industry experience. Trained at Duke University in Physiology and Pharmacology, he began his career at Merck, Sharp & Dohme and has played pivotal roles in the development of multiple approved therapies, including Sustiva®, Fablyn®, Viviant®, PanRetin®, TargRetin®, Promacta® and Eliquis®. At Image Analysis Group, Dr. Stein supports biopharmaceutical partners in shaping clinical development strategy and optimizing discovery platforms and portfolios in oncology and immuno-oncology programs.
Prof. Ali Mobasheri

Osteoarthritis Drug Development Expert

Prof. Ali Mobasheri is a world-class biomarker and imaging scientist, leading global efforts to integrate imaging, omics, and biomarker-driven approaches for novel treatments in autoimmune and musculoskeletal diseases. He is Professor, Project Leader, and Senior Research Scientist at the State Research Institute Centre for Innovative Medicine in Vilnius, and has previously held senior academic roles at the Universities of Surrey, Nottingham, and Liverpool, as well as a visiting distinguished scientist position at King Abdulaziz University.
​
He successfully coordinated the EU FP7 D-BOARD consortium and is a member of the EU IMI-funded APPROACH osteoarthritis consortium, while also consulting for multiple pharmaceutical and biotech companies. In addition to his work with IAG, he serves as President-Elect and former President of the Osteoarthritis Research Society International (OARSI) and sits on the Scientific Advisory Board for the SEN-OA project targeting senescent cells in osteoarthritis.
Cristiano Costa

Senior Product Manager
AI & Medical Imaging Expert

Cristiano Costa is a Senior Product Manager at Image Analysis Group (IAG), bringing more than a decade of cross-sectional imaging experience and a strong background in healthcare management. He combines hands-on expertise as a senior radiographer and MRI specialist with product leadership, overseeing the full lifecycle of imaging solutions from concept to deployment.

At IAG, Cristiano has progressed from Imaging Specialist to Product Manager and now Senior Product Manager, leading development of advanced imaging products with a focus on DICOM data analysis and AI-driven applications. His work spans product strategy, market research, and stakeholder engagement with pharma, healthcare providers, and research institutions, while his earlier roles in MRI protocol development, image quality assurance, and staff training underpin a deep understanding of real-world radiology workflows and clinical needs.
Roy El Zeghondi

Senior Product Manager
AI Specialist & Healthcare Engineer

Roy is a Senior Product Manager at Image Analysis Group (IAG), with over a decade of experience across healthcare engineering, product management, and AI-driven medical imaging. He combines a strong technical foundation in software design, image processing, AI, and machine learning with practical experience installing medical equipment and validating complex computer systems in regulated healthcare environments.
​
At IAG, Roy leads the design and integration of advanced AI solutions, including neuro-oncology tumor segmentation, neuroimaging analysis, and musculoskeletal and oncology data analysis. His work spans end-to-end product lifecycle ownership, workflow optimisation, and close collaboration with cross-functional teams, ensuring streamlined clinical workflows and robust, compliant platforms that support the success of IAG’s partners.

Talk to a IAG Specialist

If you are planning a clinical trial which involves imaging to assess safety or efficacy of your drug, speak to our team and propose an optimal solution for your imaging data management and review.